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Background: Exercise training programmes for patients with COPD are effective in improving
exercise capacity. The few trials that have investigated the effects of exercise programmes
on daily physical activity show contradictory results.
Aim: To investigate the relation between daily physical activity level and exercise capacity in
patients with COPD using data of a randomised controlled trial in which the exercise intervention
was aimed at improvement of both physical activity and exercise capacity (the COPE-II study).
Methods: These are secondary analyses of the COPE-II study, a randomised controlled trial in
which a community-based physiotherapeutic exercise programme was evaluated. Daily physical
activity was measured with a pedometer (steps/day). Exercise capacity was measured with an
incremental maximal cycle ergometer test, the incremental (ISWT) and endurance shuttle walk
test (ESWT). Pearson correlation coefficients were calculated.
Results: At baseline, correlations between steps/day and VO2peak, ISWT (m), ESWT (m) and ESWT
(s) were 0.54, 0.59, 0.44, and 0.34, respectively (all p < 0.01). In the intervention group, corre-
lations between change in steps/day over 7 months and change in ISWT (m), ESWT (m) and ESWT
(s) were 0.47, 0.41, and 0.38, respectively (all p< 0.01). In the control group, these same corre-
lations were weak to non-existent.
Conclusions: Amoderate toweak relationshipwas foundbetweendaily physical activity andexer-
cise capacity. These results strengthen our beliefs that exercise interventions need to target not34873666; fax: þ31 534872676.
(M. Zwerink).
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Daily physical activity and exercise capacity and in COPD 243only exercise capacity but also behaviour change with regard to daily physical activity to achieve
improvements in both parameters.
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Chronic obstructive pulmonary disease (COPD) is not only
characterized by symptoms of dyspnoea, chronic cough,
and sputum production, but also by a decreased exercise
performance1 and reduced physical activity level.2e4 There
is a large number of randomised controlled trials investi-
gating the effects of exercise training programmes,
whether part of a pulmonary rehabilitation programme or
not, on exercise capacity in patients with COPD. A meta-
analysis of Lacasse et al.5 included 31 randomised trials
and found that rehabilitation programmes including exer-
cise therapy are effective in improving exercise capacity
and quality of life. As a result, international guidelines
recommend pulmonary rehabilitation for patients with
chronic respiratory disease, and specifically for patients
with COPD.1
Most exercise training programmes for patients with
COPD focus on improvement of exercise capacity which is
reflected in the outcome measures. The incremental
maximal cycle ergometry test is the ‘gold standard’ for
measuring exercise capacity.6 However, this laboratory-
based test requires specialised equipment and knowledge,
which makes it a relatively expensive test. Frequently used
alternatives test are the field-based walking tests: the
internally paced six-minute walk test (6MWT)7 and the
externally paced incremental and endurance shuttle walk
tests (ISWT and ESWT).8,9
A minimum of 30 min of physical activity at a moderate
intensity, on at least 5 days per week, is recommended for
elderly adults, and adults with a clinically significant
chronic condition to improve and maintain health.10 In the
Netherlands, half of the patients with chronic respiratory
diseases (asthma and COPD) do not meet this criterion.11
This percentage will probably even be higher in a pop-
ulation of solely patients with COPD.12 Compared to healthy
subjects, patients with COPD spend significantly less time
walking and standing, and more time sitting and lying.2
Recent studies show that physical activity level gradually
declines with severity of disease.3,4 In COPD patients,
regular physical activity leads to general health benefits
such as a reduced risk for cardiovascular disease, stroke,
and colon cancer,13 but also to a lower risk for COPD-
related hospitalisations and mortality.14 Waschki and
colleagues even state that the level of physical activity is
the strongest predictor for all-cause mortality in patients
with COPD.15 On the shorter term, when participation in
a rehabilitation programme leads to a permanent increase
in daily physical activity, this might contribute to the
maintenance of beneficial effects of the programme on
exercise capacity. However, the latter is often not achieved
with the current programmes.16,17
Although there is an extensive amount of research on the
effects of exercise programmes on exercise capacity, onlya few trials investigated the effects on daily physical
activity in patients with COPD.18e20 These studies showed
contradictory results, which is probably due to the variation
in length and content of the interventions. Whereas an
increase in exercise capacity can be achieved with exercise
programmes as short as 4 weeks,1 an increase in daily
physical activity is elicited by a change in habits and
behaviours of the sedentary patient with COPD, and is thus
more time-consuming.17,19 Therefore, it is likely that there
is a difference in concept between exercise capacity and
daily physical activity.21 Hence, we hypothesise that
a positive change in exercise capacity does not necessarily
lead to an increase in daily physical activity and vice versa.
Several earlier studies have investigated daily physical
activity in relation to exercise capacity. In the majority of
the studies the latter was measured with the 6MWT.2,15,22e28
The relationship between physical activity and the ESWT
and ISWT is less thoroughly investigated.26 Using the data of
a previous published randomised controlled trial in patients
with COPD,20 in which the exercise intervention was aimed
at change in both exercise capacity and daily physical
activity, we further investigated the relationship between
exercise capacity and daily physical activity. With these
secondary analyses, we were among the first to investigate
the relationship between change in exercise capacity and
change in daily physical activity in patients who partici-
pated in the exercise programme and patients who received
usual care. In addition, we have explored whether other
patient characteristics were correlated with physical
activity at baseline, and with change in physical activity.
Methods
Detailed methods of the COPE-II study have been published
elsewhere.20,29
Subjects
Patients eligible for inclusion had a clinical diagnosis of
COPD according to the GOLD criteria30; a post-
bronchodilator FEV1 between 25 and 80% of predicted; at
least 3 exacerbations or one hospitalisation for respiratory
problems in the two years preceding study entry. Patients
were excluded when they had a serious other disease with
a low survival rate; another disease that influenced bron-
chial symptoms and/or lung function; a need for regular
oxygen therapy; a disorder or progressive disease that
seriously influenced walking ability.
Study design
All patients included in the COPE-II study participated in four
self-management sessions. The intention was to change the
patient’s disease behaviour by increasing their knowledge,
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and helping patients acquire and practice skills to deal with
different components of their disease. Subsequently, only the
intervention group participated in a community-based physi-
otherapeutic exercise programme (COPE-active). This pro-
gramme was divided in two parts: a ‘compulsory’ 6-month,
anda subsequentoptional but recommended5-month training
period. In the first period, patients trained three times per
week, and in the second period patients trained two times per
week. In both periods, one training session per week was
performed at home to encourage the patients to exercise in
their own environment. The training sessions consisted of
cycling, walking, climbing stairs, and lifting weights. Besides
improvement of physical condition, the main goal of COPE-
activewas a behaviour change towards exercise. The intensity
of the programme was tailored to the individual patient’s
performance level by providing the physiotherapist with the
baseline results of the incremental maximal cycle ergometry
test, and the incremental shuttle walk test.20Measurements
Exercise capacity
Incremental maximal cycle ergometer test
At baseline, patients in the COPE-active group performed an
incremental maximal cycle ergometer test on an electroni-
cally braked cycle ergometer. The tests started with two
minutes of seated rest followedby threeminutes of unloaded
cycling. After this, the workload was increased with 10, 15 or
20 W each minute depending on the patient’s height, weight
and age. The patients were instructed to cycle at a speed of
60e70 rpm, and were encouraged to continue cycling until
exhaustion. During the test, patients breathed through
a facemask connected to a calibrated metabolic cart.
Expired gas passed through a flow metre, oxygen (O2) ana-
lyser and a carbon dioxide (CO2) analyser. The flowmetre and
gas analysers were connected to a computer, which calcu-
lated breath-by-breath minute ventilation (VE), oxygen
uptake (VO2), carbon dioxide output (VCO2) and the respi-
ratory exchange ratio (RERZ VCO2/VO2) from conventional
equations. Heart rate (HR)wasmeasuredcontinuously during
the exercise test by electrocardiogram (ECG). Peak oxygen
consumption (VO2peak) was calculated as the average value
over the last 30 s before subjective exhaustion.
Incremental shuttle walk test
The ISWT was conducted according to the protocol of Singh
et al.9 Patients were instructed to walk along a 10-m course,
and to turn around at the cones at either end in timewith the
audio signal. The test started at a walking speed of 0.5 m/s,
and each minute the speed increased with 0.17 m/s. The
maximum duration of the test was 12 min. However, the test
was terminated earlier when the patient indicated not to be
able to continue due to fatigue or dyspnoea, or when the
patient failed to reach the cone in the time allowed. The
ISWT was performed at baseline, 7, and 12 months. At
baseline, each patient performed a practice walk.9
Endurance shuttle walk test
The ESWT was also performed on a 10-m course.8 After
a warming up period of 120 s, walking speed increased andwas constant during the test. Walking speed was set at 85%
of the patient’s maximum capacity as predicted from the
distance walked during the ISWT. The maximal duration of
the test was 20 min, and the criteria to stop the test were
the same as described for the ISWT.9 The ESWT was per-
formed at baseline, 7, and 12 months.
Daily physical activity level
Pedometer
Daily physical activity was assessed by the number of steps
perdaymeasuredwith theYamaxDigi-Walker SW-200 (Tokyo,
Japan). Patientswere instructed towearapedometer for a 7-
dayperiod, and tonote thenumber of steps in a daily diary, at
baseline, 7, and 12 months. Daily physical activity was
calculated by summing up the number of steps over 7 days,
and then averaging it by that same number of days.20
Other measurements
At baseline, lung functionwas assessed using spirometry. The
forced expiratory volume in one second (FEV1) and vital
capacity (VC) were measured. Also, the Medical Research
Council (MRC) dyspnoea scale was administered,31 and
anthropometry and demographic variables were collected.
Statistical analysis
Baseline characteristics are reported as mean  SD for
continuous variableswith a normal distribution, or asmedian
and range when not normally distributed. Categorical vari-
ables are presented as number with percentage. The rela-
tionship between continuous variables was tested by
calculating Pearson or Spearman correlation coefficients,
depending on the normality of the distribution of the vari-
ables. Correlation coefficients were considered to be
statistically significant when the p-value was smaller than
0.05. All analyses were performed using SPSS version 15.0.
Results
One hundred fifty nine patients were included in the COPE-
II study, 80 patients were randomised to participation in the
community-based physiotherapeutic exercise programme
(COPE-active) and 79 patients were randomised to the
control group. In both study groups, three patients dropped
out between randomisation and baseline measurements.
Table 1 shows the baseline characteristics of the remaining
153 patients.
Relationship between daily physical activity and
exercise capacity at baseline
The Pearson correlation coefficients between steps/day
and ISWT (m), ESWT (m), and ESWT (s) at baseline were
calculated for the patients in both study groups together
(n Z 125), and were 0.59, 0.44, and 0.34, respectively
(p < 0.01 for all). Pearson correlation coefficients between
steps/day on the one hand and VO2peak and Wpeak on the
other hand were only calculated for the COPE-active group
(n Z 57 and n Z 58, respectively), and were 0.54
(p < 0.001) and 0.44 (p Z 0.001) respectively.
Table 1 Baseline characteristics.
Total COPE-active (n Z 77) Control (n Z 76)
Age (years) 63.6  7.9 62.9  8.1 63.9  7.8
Male (%) 58.2 58.4 57.9
Smokers (%) 34.6 35.1 34.2
MRC dyspnoea scale 2.37  1.11 2.25  1.05 2.50  1.15
FEV1 (L) 1.41  0.53 1.43  0.54 1.40  0.53
FEV1% predicted value 50.2  15.6 49.6  14.2 50.5  17.0
IVC (L) 3.63  0.97 3.78  1.05 3.47  0.84
BMI (kg/m2) 26.5  4.72 26.1  5.0 26.8  4.4
Daily physical activity level (steps/day)a 4857  3132 4472  2716 5224  3464
Incremental shuttle walk test (m)b 365.0  159.9 387.7  164.5 341.4  152.4
Endurance shuttle walk test (m)b 654.7  552.3 678.9  553.1 629.5  554.1
Endurance shuttle walk test (s)b 505.7  370.3 503.7  368.1 507.9  375.1
VO2peak (ml/kg/min)
c n.a. 18.05  5.03 n.a.
Wpeak (watt)
d n.a. 93.38  47.67 n.a.
Medical Research Council (MRC); Forced Expiratory Volume in 1 s (FEV1); Inspiratory Vital Capacity (IVC); Body Mass Index (BMI); Peak
oxygen uptake (VO2peak); Peak wattage (Wpeak).
a Based on 62 patients in the COPE-active group and 65 patients in the control group.
b Based on 77 patients in the COPE-active group and 74 patients in the control group.
c Based on 69 patients in the COPE-active group.
d Based on 71 patients in the COPE-active group.
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activity and change in exercise capacity at 7 and 12
months
The correlations between change in daily physical activity
and change in the various measures of exercise capacityTable 2 Pearson correlation coefficients between change
in daily physical activity and change in exercise capacity
from baseline to 7 and 12 months for the COPE-active and
control group.
D 0e7 months Daily physical activity (steps/day)
D 0e7 months
COPE-active
(n Z 53)
Control
(n Z 48)
r p r p
Incremental shuttle
walk test (m)
0.47 <0.001 0.11 0.48
Endurance shuttle
walk test (m)
0.41 0.003 0.05 0.74
Endurance shuttle
walk test (s)
0.38 0.006 0.05 0.74
D 0e12 months Daily physical activity (steps/day)
D 0e12 months
COPE-active
(n Z 54)
Control
(n Z 54)
r p r p
Incremental shuttle
walk test (m)
0.40 0.003 0.09 0.54
Endurance shuttle
walk test (m)
0.18 0.21 0.10 0.46
Endurance shuttle
walk test (s)
0.17 0.22 0.17 0.23after 7 months of follow-up were moderate in the COPE-
active group (p < 0.01 for all), and negligible and not
statistically significant in the control group (Table 2). After
12 months, only the correlation between change in ISWT
distance and change in steps/day in the COPE-active group
was moderate and statistically significant (Table 2).
Relationship between daily physical activity and
patient characteristics at baseline
The Pearson correlation coefficients between steps/day on
one hand and FEV1, IVC, age and Body Mass Index (BMI) at
baseline on the other hand were calculated for the patients
in both study groups together (n Z 127), and were 0.32
(p < 0.001), 0.17 (p Z 0.05), 0.23 (p Z 0.01), and 0.09
(p Z 0.29) respectively.
Relationship between change in daily physical
activity from baseline to 7 months and patients
characteristics at baseline
In the COPE-active group as well as in the control group,
none of the variables measured at baseline was significantly
correlated to change in daily physical activity from baseline
to 7 months (Table 3).
Discussion
The current study showed that daily physical activity and
exercise capacity were only moderately correlated in
patients with COPD. Additionally, in patients with COPD
who participated in a physiotherapeutic exercise pro-
gramme, the relationship between change in exercise
capacity and change in daily physical activity was moderate
to weak. In the control group, change in exercise capacity
and change in daily physical activity were not correlated.
Table 3 Pearson correlation coefficients between change
in daily physical activity from baseline to 7 months and
patient characteristics at baseline for the COPE-active and
control group.
D Steps/day 0e7months
COPE-active Control
r p r p
VO2peak (ml/kg/min)
a 0.22 0.11 n.a. n.a.
Wpeak (watt)
b 0.21 0.12 n.a. n.a.
Incremental shuttle
walk test (m)c
0.05 0.70 0.04 0.78
Endurance shuttle
walk test (m)c
0.08 0.53 0.07 0.64
Endurance shuttle
walk test (s)c
0.1 0.47 0.07 0.60
FEV1 (L)
d 0.08 0.55 0.13 0.94
IVC (L)d 0.00 0.98 0.06 0.69
Age (years)d 0.06 0.63 0.09 0.55
BMI (kg/m2)d 0.19 0.14 0.02 0.89
Peak oxygen uptake (VO2peak); Peak wattage (Wpeak); Forced
Expiratory Volume in 1 s (FEV1), Inspiratory Vital Capacity (IVC);
Body Mass Index (BMI).
a Based on 54 patients in the COPE-active group.
b Based on 55 patients in the COPE-active group.
c Based on 59 patients in the COPE-active group and 50
patients in the control group.
d Based on 59 patients in the COPE-active group and 52
patients in the control group.
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between daily physical activity and exercise capacity in
patients with COPD. The studies that investigated the
relationship between daily physical activity and VO2peak
show divergent results with correlations varying from weak
to moderate.2,24e26 This variety in correlations might be
due to differences in patient characteristics and the
method of measuring physical activity. Hill and colleagues
were recently the first to investigate daily physical activity
in relation to performance on the incremental shuttle walk
test.26 In this study, daily physical activity was measured in
26 subjects with bi-axial accelerometers and expressed as
daily energy expenditure in kcal. They found a statistically
significant correlation of 0.52 between distance walked on
the incremental shuttle walk test and daily energy expen-
diture.26 Whereas we have measured daily physical activity
with pedometers, we have found a similar correlation of
0.59 between steps per day and distance walked on the
incremental shuttle walk test. Pedometers are relatively
simple and inexpensive compared to other activity monitors
such as accelerometers. In our study we used the Yamax
Digi-Walker SW-200. The mechanism of the SW-200 is the
same as the mechanism of the SW-701 and this latter
pedometer was considered to be among the most accurate
ones in comparison with 9 other models.32,33 In a more
recent study, Turner et al. compared a pedometer to an
activity monitor with an accelerometer and both devices
underestimated step counts at slow walking speed.34 In the
original COPE-II study pedometers were used to measure
the level of physical activity in the intervention and controlgroup, in case of underestimation this would be expected in
the same amount in both groups, and would thus have not
affected difference between the groups.
To our knowledge, we are the first to investigate daily
physical activity in relation to the endurance shuttle walk
test. The relationship between physical activity and
endurance time of the ESWT at baseline seems weaker than
the relationship between activity and distance walked
during the ISWT, and it seems also weaker than the rela-
tionship between daily physical activity and VO2peak. This is
contrary to what we expected to find. Patients with COPD
perform their activities of daily living at a submaximal level
of intensity.26 The ESWT measures endurance capacity also
at a submaximal level of intensity, and therefore we
assumed that performance on the ESWT would better
reflect the level of daily physical activity. However,
a recent other study of Hill et al. gives more insight by
indicating that peak rates of oxygen uptake and peak heart
rates that patients with moderate COPD achieve during the
ESWT are similar to rates achieved during the cycle ergo-
metry test and the ISWT.35
Opposite to the limited research on the relationship
between daily physical activity and the shuttle walking
tests, the six-minute walk test (6MWT) has been investi-
gated more thoroughly. In the majority of the studies, daily
physical activity relates slightly better with the 6MWT than
that it relates with the ISWT and ESWT in our study.2,15,22e28
During the 6MWT patients are instructed to walk at their
own pace, and cover as much ground as they can within
6 min, moreover, patients are allowed to stop and rest
during the test.7 This differs from the ISWT and the ESWT,
in which patients are instructed to walk at a predetermined
speed until they are not able to continue due to dypsnoea
or fatigue.8,9 Pepin et al. showed a significantly higher
heart rate, respiratory rate, minute ventilation and dysp-
noea after completing the ESWT than after completing the
6MWT in patients with COPD.36 In contrast, Hill and
colleagues found no differences between VO2peak and heart
rate after completion of the 6MWT, ESWT, ISWT and CPET in
patients with COPD.35 Patients in the latter study were
functionally more impaired than the patients in the study of
Pepin et al. This might explain why the 6MWT seems to
relate better to exercise behaviour and the submaximal
intensity of daily physical activity in patients with mild
COPD.
The strongest, although moderate, relation between
change in physical activity and change in exercise capacity
was found in the intervention group over the first 7 months.
In this period, the number of moments for goal setting and
feedback were the most frequent (four self-management
sessions, and subsequently two training session per week at
the physiotherapy practice and one training session per
week at home). We therefore expected, and also detected
a mean improvement in both exercise capacity and daily
physical activity. During the following five months, the
intervention was less intense (one exercise sessions at
home, and one supervised physiotherapy session). We
anticipated that the less intense training approach, but still
frequent feedback and reinforcement would be necessary
to maintain exercise capacity and further facilitate a shift
towards being more active at home. After this second
period, we observed a slight decrease in exercise capacity,
Daily physical activity and exercise capacity and in COPD 247this in contrast to a further increase in daily physical
activity. Over 12 months, the relationship between activity
and performance on the ISWT, and in particular the ESWT
was weakened. The weakening of the relationship after
including the period in which the intervention was primarily
focused on improvement of daily physical activity, under-
lines the need to use interventions that target not only
exercise capacity but also health behaviour regarding
exercise in patients with COPD to achieve an increase in
both parameters.
In the COPE-active group as well as in the control group,
none of the patient characteristics measured at baseline
were correlated with change in daily physical activity over
7 months. However, nearly all of these parameters were of
a physiological nature, which are not the only variables
influencing activities.37 Daily activities are also influenced
by environmental and personal factors.37 Environmental
factors make up the physical, social, and attitudinal envi-
ronment in which people live and conduct their lives.37
Personal factors are the particular background of an indi-
vidual’s life and living and contribute to features of the
individual. These factors include sex, race, age, but also
lifestyle, coping styles, social background, education,
overall behaviour patterns and other characteristics.37 One
of the main objectives in the COPE-II study was to assess
the efficacy of a self-management programme, including
a community-based physiotherapeutic exercise programme
in increasing exercise capacity and daily physical activity.
With the exception of steps per day no further (process)
measures of behavioural change were measured. In future
research on daily physical activity in patients with COPD,
more attention should be paid to the role of behavioural
characteristics and psychosocial factors such as self-
efficacy, emotional status, and social functioning.
Another remark that can be made, is that by including
patients with at least three exacerbations in the two years
preceding study entry, we have included relatively severe
COPD patients. The COPE-II study was also designed to
investigate the effectiveness of self-treatment of exacer-
bations,29 and the criterion of at least three exacerbations
was used to ensure that a sufficient number of exacerba-
tions could be detected during study follow-up. How this
has affected the level of daily physical in our patients is
hard to determine. Only few studies have assessed step
count in patients with COPD using a pedometer, and the
sample size of these studies was small. However, Hospes
et al. alsomeasured daily physical activity during 7 days with
the Digi-Walker SW-200 in 39 Dutch patients with COPD.
Compared to the patients in this study, the patients in our
study reported on average fewer steps: 7087  4058 steps
versus 4857 3132 steps, respectively.38 This is probably due
to the less restrictive inclusion criteria in the study of Hospes
et al., which is also reflected in a higher mean FEV1% of
predicted of 67.4 17.5% versus 50.2 15.6% in our study. A
consequence for the current analyses might be that the
results cannot be generalised to the general COPD pop-
ulation, but only to the more severe patients.
Although we found statistically significant correlations
between daily physical activity and different measures of
exercise capacity, these correlations were at best
moderate. What do these results mean for clinical practice?
The primary goal of exercise programmes for patients withCOPD, as part of a pulmonary rehabilitation programme or
not, is improvement of exercise capacity.1 Intuitively it is
logical to assume that an increased exercise capacity will
subsequently lead to an increased physical activity level.
An increased exercise capacity in patients with COPD
reduces symptoms of dyspnoea and fatigue during and after
exercise and therefore removes a barrier to be active.
However, during the years that the severity of COPD grad-
ually progresses, the patient develops a sedentary lifestyle
that needs more than an increase in exercise capacity to
change.21 Behavioural techniques such as motivational
interviewing and cognitive behavioural therapy are prob-
ably helpful in achieving and maintaining an improved daily
physical activity level. However, future research has to
investigate which tools are most effective in increasing
daily physical activity.
In this study, a moderate to weak relationship was found
between daily physical activity and exercise capacity.
These results strengthen our beliefs that exercise inter-
ventions need to target not only exercise capacity but also
behaviour change with regard to daily physical activity, to
achieve improvement in both parameters.Sources of funding
This work was supported by the Netherlands Asthma
Foundation, grant numbers 3.4.07.038 and 3.4.02.12.Conflict of interest statement
There are no conflicts of interest.References
1. Nici L, Donner C, Wouters E, ZuWallack R, Ambrosino N,
Bourbeau J, et al. American Thoracic Society/European
Respiratory Society statement on pulmonary rehabilitation. Am
J Respir Crit Care Med 2006 Jun 15;173(12):1390e413.
2. Pitta F, Troosters T, Spruit MA, Probst VS, Decramer M,
Gosselink R. Characteristics of physical activities in daily life in
chronic obstructive pulmonary disease. Am J Respir Crit Care
Med 2005 May 1;171(9):972e7.
3. Troosters T, Sciurba F, Battaglia S, Langer D, Valluri SR,
Martino L, et al. Physical inactivity in patients with COPD,
a controlled multi-center pilot-study. Respir Med 2010 Jul;
104(7):1005e11.
4. Watz H, Waschki B, Meyer T, Magnussen H. Physical activity in
patients with COPD. Eur Respir J 2009 Feb;33(2):262e72.
5. Lacasse Y, Martin S, Lasserson TJ, Goldstein RS. Meta-analysis
of respiratory rehabilitation in chronic obstructive pulmonary
disease. A Cochrane systematic review. Eura Medicophys 2007
Dec;43(4):475e85.
6. Palange P, Ward SA, Carlsen KH, Casaburi R, Gallagher CG,
Gosselink R, et al. Recommendations on the use of exercise
testing in clinical practice. Eur Respir J 2007 Jan;29(1):
185e209.
7. ATS statement: guidelines for the six-minute walk test. Am J
Respir Crit Care Med 2002 Jul 1;166(1):111e7.
8. Revill SM, Morgan MD, Singh SJ, Williams J, Hardman AE. The
endurance shuttle walk: a new field test for the assessment of
endurance capacity in chronic obstructive pulmonary disease.
Thorax 1999 Mar;54(3):213e22.
248 M. Zwerink et al.9. Singh SJ, Morgan MD, Scott S, Walters D, Hardman AE. Devel-
opment of a shuttle walking test of disability in patients with
chronic airways obstruction. Thorax 1992 Dec;47(12):1019e24.
10. Nelson ME, Rejeski WJ, Blair SN, Duncan PW, Judge JO,
King AC, et al. Physical activity and public health in older
adults: recommendation from the American College of Sports
Medicine and the American Heart Association. Med Sci Sports
Exerc 2007 Aug;39(8):1435e45.
11. Chorus AMJ. Bewegen in Nederland: chronisch zieken. In:
Hildebrandt VH, Chorus AMJ, Stubbe JH, editors. Trendrapport
Bewegen en Gezondheid 2008/2009. Leiden: De Bink; 2010. p.
95e108.
12. Eliason G, Zakrisson AB, Piehl-Aulin K, Hurtig-Wennlof A.
Physical activity patterns in patients in different stages of
chronic obstructive pulmonary disease. COPD 2011 Oct;8(5):
369e74.
13. Blair SN, Cheng Y, Holder JS. Is physical activity or physical
fitness more important in defining health benefits? Med Sci
Sports Exerc 2001 Jun;33(Suppl. 6):S379e99.
14. Garcia-Aymerich J, Lange P, Benet M, Schnohr P, Anto JM.
Regular physical activity reduces hospital admission and
mortality in chronic obstructive pulmonary disease: a pop-
ulation based cohort study. Thorax 2006 Sep;61(9):772e8.
15. Waschki B, Kirsten A, Holz O, Muller KC, Meyer T, Watz H, et al.
Physical activity is the strongest predictor of all-cause
mortality in patients with COPD: a prospective cohort study.
Chest 2011 Aug;140(2):331e42.
16. Spruit MA, Troosters T, Trappenburg JC, Decramer M,
Gosselink R. Exercise training during rehabilitation of patients
with COPD: a current perspective. Patient Educ Couns 2004
Mar;52(3):243e8.
17. Wempe JB, Wijkstra PJ. The influence of rehabilitation on
behaviour modification in COPD. Patient Educ Couns 2004 Mar;
52(3):237e41.
18. Mador MJ, Patel AN, Nadler J. Effects of pulmonary rehabili-
tation on activity levels in patients with chronic obstructive
pulmonary disease. J Cardiopulm Rehabil Prev 2011 Jan;31(1):
52e9.
19. Pitta F, Troosters T, Probst VS, Langer D, Decramer M,
Gosselink R. Are patients with COPD more active after
pulmonary rehabilitation? Chest 2008 Aug;134(2):273e80.
20. Effing T, Zielhuis G, Kerstjens H, van der Valk P, van der
Palen J. Community based physiotherapeutic exercise in COPD
self-management: a randomised controlled trial. Respir Med
2011 Mar;105(3):418e26.
21. Larson JL. Functional performance and physical activity in
chronic obstructive pulmonary disease: theoretical perspec-
tives. COPD 2007 Sep;4(3):237e42.
22. Behnke M, Wewel AR, Kirsten D, Jorres RA, Magnussen H.
Exercise training raises daily activity stronger than predicted
from exercise capacity in patients with COPD. Respir Med 2005
Jun;99(6):711e7.
23. Belza B, Steele BG, Hunziker J, Lakshminaryan S, Holt L,
Buchner DM. Correlates of physical activity in chronic obstruc-
tive pulmonary disease. Nurs Res 2001 Jul;50(4):195e202.
24. Garcia-Rio F, Lores V, Mediano O, Rojo B, Hernanz A, Lopez-
Collazo E, et al. Daily physical activity in patients with chronicobstructive pulmonary disease is mainly associated with
dynamic hyperinflation. Am J Respir Crit Care Med 2009 Sep
15;180(6):506e12.
25. Hernandes NA, Teixeira DC, Probst VS, Brunetto AF, Ramos EM,
Pitta F. Profile of the level of physical activity in the daily lives
of patients with COPD in Brazil. J Bras Pneumol 2009 Oct;
35(10):949e56.
26. Hill K, Dolmage TE, Woon L, Coutts D, Goldstein R, Brooks D.
Defining the relationship between average daily energy
expenditure and field-based walking tests and aerobic reserve
in COPD. Chest 2012 Feb;141(2):406e12.
27. Jehn M, Schmidt-Trucksass A, Meyer A, Schindler C, Tamm M,
Stolz D. Association of daily physical activity volume and inten-
sity with COPD severity. Respir Med 2011 Dec;105(12):1846e52.
28. Steele BG, Holt L, Belza B, Ferris S, Lakshminaryan S,
Buchner DM. Quantitating physical activity in COPD using
a triaxial accelerometer. Chest 2000 May;117(5):1359e67.
29. Effing T, Kerstjens H, van der Valk P, Zielhuis G, van der
Palen J. (Cost)-effectiveness of self-treatment of exacerba-
tions on the severity of exacerbations in patients with COPD:
the COPE II study. Thorax 2009 Nov;64(11):956e62.
30. Rabe KF, Hurd S, Anzueto A, Barnes PJ, Buist SA, Calverley P,
et al. Global strategy for the diagnosis, management, and
prevention of chronic obstructive pulmonary disease: GOLD
executive summary. Am J Respir Crit Care Med 2007 Sep 15;
176(6):532e55.
31. Bestall JC, Paul EA, Garrod R, Garnham R, Jones PW,
Wedzicha JA. Usefulness of the Medical Research Council
(MRC) dyspnoea scale as a measure of disability in patients
with chronic obstructive pulmonary disease. Thorax 1999 Jul;
54(7):581e6.
32. Crouter SE, Schneider PL, Karabulut M, Bassett Jr DR. Validity
of 10 electronic pedometers for measuring steps, distance, and
energy cost. Med Sci Sports Exerc 2003 Aug;35(8):1455e60.
33. Schneider PL, Crouter SE, Lukajic O, Bassett Jr DR. Accuracy
and reliability of 10 pedometers for measuring steps over
a 400-m walk. Med Sci Sports Exerc 2003 Oct;35(10):1779e84.
34. Turner LJ, Houchen L, Williams J, Singh SJ. Reliability of
pedometers to measure step counts in patients with chronic
respiratory disease. J Cardiopulm Rehabil Prev 2012 Sep;
32(5):284e91.
35. Hill K, Dolmage TE, Woon L, Coutts D, Goldstein R, Brooks D.
Comparing peak and submaximal cardiorespiratory responses
during field walking tests with incremental cycle ergometry in
COPD. Respirology 2012 Feb;17(2):278e84.
36. Pepin V, Brodeur J, Lacasse Y, Milot J, Leblanc P, Whittom F,
et al. Six-minute walking versus shuttle walking: responsive-
ness to bronchodilation in chronic obstructive pulmonary
disease. Thorax 2007 Apr;62(4):291e8.
37. World Health Organization. International classification of
functioning, disabilities, and health: ICF 2001 [Geneva. Ref
Type: Generic].
38. Hospes G, Bossenbroek L, Ten Hacken NH, van HP, de
Greef MH. Enhancement of daily physical activity increases
physical fitness of outclinic COPD patients: results of an
exercise counseling program. Patient Educ Couns 2009 May;
75(2):274e8.
